Peptides promoting angiogenesis ( BPC-157 ) potentially critical for revascularizing damaged bone
BPC-157 (Body Protection Compound-157) drives angiogenesis and upregulates growth factors including VEGF and TGF-, building the vascular infrastructure needed for tissue repair
However, raised liver enzymes, vomiting, dehydration, and decreased appetite were reported as some of the side effects (LoRusso et al., 2022)
Common current practice in other research laboratories is to store the reconstituted working stock at 2 to 8C, protected from light, and use it within roughly 28 to 30 days
Regarding the lung cancer findings: With a number needed to harm of approximately 2,000 over six years, the absolute risk increase for any individual is small